Covidien LP

Edwards Lifesciences Corporation

Carefusion 303, Inc.

Other

Baxter International Inc.

Interventional Technologies, Inc.

Lawrence J Farhat

Gabriel Newell

Andy Huynh

Qinggang Zeng

Rafael Pintor

August R Yambao

Faisal Kalam

William Charles Brunnett

Michael J Scott

Michael Losordo

Harvey H Chen

Andrew Phung

Carey L Cristea

Kevin W Zheng

Sara M Walls

Louis A Campbell

Travis Zenyo Oba

Tammy Huntley

Thomas H Chien

Evan Epstein

Robert Steven Vasko

Kenneth Brown

Abhishek Gautam

Ghislain Sema

Fred Hodshon

George Michel Mansour

Robert Dwaine Butterfield

David Lee Foshee

Edward Paul Browka

Ashok Nageswaran

Daniel M Abal

Stephen Bollish

Theodore Mosler

James Fentress

Mooneer Thabet Salem

Frederic B Hodshon

Kenneth Holloway

Edwin Wang

Garrett Dallas Johnson

David P Balding

Li-Chien Hsu

Hieu Minh Luong

Aaron Barrett

Abishek Gautam

Thomas Y Chien

David Franco

Stephen J Bollish

Faisai Kalam

Thomas Chien

Michael L Losordo

Evan David Epstein

Qinggang Zenq

Gabriel F Newell

A quick-connect heart valve prosthesis that can be quickly and easily implanted during a surgical procedure is provided. The heart valve includes a substantially non-expandable, non-compressible prosthetic valve and a plastically-expandable frame, thereby enabling attachment to the annulus without sutures. A small number of guide sutures may be provided for aortic valve orientation. The prosthetic valve may be a commercially available valve with a sewing ring with the frame attached thereto. The frame may expand from a conical deployment shape to a conical expanded shape, and may include web-like struts connected between axially-extending posts. A system and method for deployment includes an integrated handle shaft and balloon catheter. A valve holder is stored with the heart valve and the handle shaft easily attaches thereto to improve valve preparation steps.

Methods for rapidly deployable surgical heart valves

A retrograde disposable intravenous (IV) set is disclosed. The IV set includes a diverter housing between upper and lower portions of a fluid line, the diverter housing including a lower end and an upper end extending away from the lower end and the fluid line to a syringe port located in the upper end, and a diverter member within the diverter housing and configured to move within the diverter housing from a first position, at which a first opening through the diverter member forms a first fluid pathway between the upper portion and the lower portion of the fluid line, to a second position, at which the first fluid pathway is blocked and a second fluid pathway is formed between the upper portion of the fluid line and a syringe port. Retrograde infusion may occur when the diverter member is in the second position.

Disposable intravenous (IV) set with flow control valve

Systems for rapidly deployable surgical heart valves

Inductive identification systems and methods are described. The system may include an inductive detector configured to identify objects having inductive identifiers. An inductive detector may include conductive coils and inductance readout circuitry for measuring an inductance of each coil. An inductive identifier may include a conductive pattern configured to induce a desired inductance in the coils of the inductive detector. An inductive identifier may include a film having openings, each opening configured to be disposed over a corresponding coil to induce differing inductance changes in the corresponding coils. A pattern of inductance values may be determined and used to identify the object. The detector may be implemented in a cassette recess of an infusion pump system. The inductive identifier may be disposed on a pump cassette configured to be received in the cassette recess and identified based on an inductive interaction between the inductive detector coils and the inductive identifier.

Systems and methods for inductive identification

Packaging for prosthetic heart valves including an assembly for securely retaining a heart valve within a jar and facilitating retrieval therefrom. The assembly includes a packaging sleeve that fits closely within the jar and has a clip structure for securing a valve holder. Contrary to previous designs, in one embodiment the valve holder is directed downward into the jar, and the valve is retained with an inflow end upward. The valve may have flexible leaflets, and a leaflet parting member on the end of the shaft extends through the leaflets and couples with the valve holder. The assembly of the packaging sleeve, valve, and holder can then be removed from the jar and a valve delivery tube connected with the holder, or to the leaflet parting member. The packaging sleeve may be bifurcated into two halves connected at a living hinge to facilitate removal from around the valve/holder subassembly.

Prosthetic heart valve packaging and deployment systems

A stent delivery system can include a core member, first and second restraints, and a stent engagement component. The core member can have a distal segment. The first and second restraints can be coupled to the core member distal segment and axially spaced apart from each other to provide an axial gap. The first and second restraints can each have an outer profile that tapers radially inwardly in directions away from the gap. The stent engagement component can be at least partially disposed in the axial gap between the first and second restraints such that the component is slidably and rotatably coupled to the core member distal segment.

Luminal stenting

Systems and methods of micro-infusion of medical fluids are disclosed. Micro-infusion systems may include a pump, a patient interface, tubing between the pump and the interface, and a micro-infusion device along the tubing. A first portion of the tubing above the micro-infusion device is longer than a second portion of the tubing below the device. The micro-infusion device may include a chamber in-line with the tubing, a first valve between the chamber and the first portion of the tubing, a second valve between the chamber and the second portion of the tubing and a third valve between the chamber and a dump chamber. The second valve may be slidably disposed within the chamber. A medical fluid may be provided into the chamber that slides the second valve displacing another fluid in the chamber through the third valve into the dump chamber.

Micro-infusion device and infusion set

A stent delivery system can include a core member, an introducer sheath, and a microcatheter. The core member can have a distal segment. The stent engagement member can have a generally tubular body positioned about the core member distal segment and can be rotatably coupled to the core member. The engagement member can include an inner layer that has a first durometer and an outer layer that has a second durometer less than the first durometer. The stent can extend along the core member distal segment such that an inner surface of the stent is engaged by the engagement member outer layer for facilitating rotation of the stent relative to the core member.

Delivery of medical devices

Systems and methods are provided for intermittent microinfusion. A system may include a pump and an IV set that includes a y-port valve disposed below a pump interface portion of the IV tubing. The y-port valve may include an internal valve member that allows fluid to flow from the pump to a patient when no syringe is attached to the y-port. The internal valve member may be moved by the attachment of a syringe containing the medication to be infused to the y-port such that the fluid pathway from the pump to the patient is blocked and fluid from the syringe can be injected into the IV tubing between the y-port valve and the pump. The pump may retrograde pump the medication into the tubing via the y-port valve and then forward pump the medication to the patient when the syringe is removed from the y-port.

Systems and methods for intermittent infusion

A system can comprise a catheter and a device having an elongate member and an expandable member. The expandable member can be coupled to the elongate member. The elongate member can extend through the catheter. The expandable member can be positioned with a proximal member end proximal to a distal catheter end, a distal member end positioned distal to the distal catheter end, and at least a portion of the expandable member between the distal catheter end and the distal member end in an expanded state in which a maximum transverse dimension of the expandable member is larger than a maximum transverse dimension of the distal member end. The catheter can be advanced in a patient's body with the expandable structure, in the expanded state, at the distal end of the catheter.

Systems and methods for catheter advancement

Growing community of inventors

Carlsbad, CA, United States of America

Lawrence J Farhat